Oncology Central

Oncolytic virotherapy for thyroid cancer: will it translate to the clinic?


Observations that viruses can induce tumor regression date back to the beginning of the 20th century [1] and the use of viruses for cancer treatment has been theorized since then ; however only in the late 1990s advancement in viral manipulation technologies together with a better understanding of the molecular alterations in cancer cells allowed the development of oncolytic viruses (virotherapy).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.